TriLink supplies reagents for SOLiD system:
This article was originally published in Clinica
Executive Summary
San Diego, California-based reagents manufacturer TriLink Biotechnologies will supply Applied Biosystems with chemically synthesised nucleotides for the latter's SOLiD genetic analysis platform. TriLink will provide Applied (Foster City, California) with custom dye-labelled nucleotides, which will be used by the SOLiD system as part of its DNA sequencing process. Financial terms of the deal were not discussed.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.